医用放射性核素生产现状和主要问题
|
摘要
放射性核素是核技术应用的重要基础,广泛应用于工业、医疗卫生等行业。本文重点介绍国际和国内医用放射性核素生产和应用的现状和存在的问题,对国内放射性核素生产和应用存在的问题进行分析,并提出建议,以促进我国放射性核素生产和应用的发展。
Radionuclide is the basic of nuclear technology application,it's widely used in manufacturing,medical and other industry area.The status and the problems in radionuclide production and application was introduced,problems in radionuclide production and application of China were also analyzed.The advice was suggested to resolve these problems to promote development of Chinese radionuclide production and application.
Radionuclide is the basic of nuclear technology application,it's widely used in manufacturing,medical and other industry area.The status and the problems in radionuclide production and application was introduced,problems in radionuclide production and application of China were also analyzed.The advice was suggested to resolve these problems to promote development of Chinese radionuclide production and application.
引文
[1]Mark J,Rivard L M,Bobek RAB,et al.The US national isotope program:Current status and strategy for future success[J].Applied Radiationand Isotopes,2005,63:157-178.
[2]Nuclear Technology Review2012.International At-omic Energy Agency[R].Vienna:IAEA,2012:43.
[3]贺佑丰.美国同位素生产和应用[J].同位素,2006,19(2):107-111.He Youfeng.Production and application of iso-tope in USA[J].Journal of Isotopes,2006,19(2):107-111(in Chinese).
[4]张华明,罗顺忠,刘国平,等.中国工程物理研究院同位素技术研究与应用进展[J].同位素,2011,24(Z1):116-120.Zhang Huaming,Luo Shunzhong,Liu Guoping et al.Isotope technologies in inpc:state of art and perspective.journal of isotope[J].Journal of Iso-topes,2011,24(Z1):116-120(in Chinese).
[5]张锦荣,罗志福.中国放射性同位素技术与应用进展[J].中国工程科学,2008,10(1):61-69.Zhang Jinrong,Luo Zhifu.Raioisotope technique and its application in china[J].Engineering Sci-ences,2008,10(1):61-69(in Chinese).
[6]贾红梅,刘伯里.中国放射性药物的现状与展望[J].同位素,2011,23(3):129-139.Jia Hongmei,Liu Boli.Current status and pros-pects of radiopharmaceuticals in china[J].Journal of Isotopes,2011,23(3):129-139(in Chinese).
[7]中华医学会核医学分会.2012年全国核医学现状普查简报引用[J].中华核医学与分子影像杂志,2012,32(5):357.Chinese Society of Nuclear Medicine.2012Nation-al census of nuclear medicine status briefing[J].Chin Journal of Nuclear Medicine and Molecular Imaging,2012,32(5):357(in Chinese).
[8]HEGER AS,WILLIAM B.Comparison of Char-acteristics of Solution and Conventional Reactors for 99 Mo Production[J].Nuclear Technology,1997,118(5):142-150.
[9]邓启民,程作用,李茂良,等.利用MIPR生产99 Mo、131 I和89 Sr的可行性研究[J].核动力工程,2011(6):79-83.Deng Qimin,Li Maoliang,Cheng Zuoyong.Fea-sibility production of molybdenum-99,iodine-131,strontium-99through medical isotope produc-tion reactor[J].Nuclear Power Engineering,2011,(6):79-83(in Chinese).
[10]邓启民,李茂良,程作用.利用医用同位素生产堆生产89 Sr[J].同位素,2007,20(3):185-188.Deng Qimin,Li Maoliang,Cheng Zuoyong.Strontium-99production through medical isotope production reactor[J].Journal of Isotopes,2007,20(3):112-115(in Chinese).
[11]邓启民,李茂良,程作用.医用同位素生产堆(MIPR)生产99 Mo的应用前景[J].核科学与工程,2006,26(2):68-70.Deng Qimin,Li Maoliang,Cheng Zuoyong.Ap-plication of molybdenum-99production through medical isotope production reactor(MIPR)[J].Chinese Journal of Nuclear Science and Engineer-ing,2006,26(2):68-70(in Chinese).
[12]Jongen Y.Adonis:The Proton-driven Neutron Source for Radioisotope Production[C]//IAEA-TECDOC-1065,Vienna:IAEA,1999:139-146.
[2]Nuclear Technology Review2012.International At-omic Energy Agency[R].Vienna:IAEA,2012:43.
[3]贺佑丰.美国同位素生产和应用[J].同位素,2006,19(2):107-111.He Youfeng.Production and application of iso-tope in USA[J].Journal of Isotopes,2006,19(2):107-111(in Chinese).
[4]张华明,罗顺忠,刘国平,等.中国工程物理研究院同位素技术研究与应用进展[J].同位素,2011,24(Z1):116-120.Zhang Huaming,Luo Shunzhong,Liu Guoping et al.Isotope technologies in inpc:state of art and perspective.journal of isotope[J].Journal of Iso-topes,2011,24(Z1):116-120(in Chinese).
[5]张锦荣,罗志福.中国放射性同位素技术与应用进展[J].中国工程科学,2008,10(1):61-69.Zhang Jinrong,Luo Zhifu.Raioisotope technique and its application in china[J].Engineering Sci-ences,2008,10(1):61-69(in Chinese).
[6]贾红梅,刘伯里.中国放射性药物的现状与展望[J].同位素,2011,23(3):129-139.Jia Hongmei,Liu Boli.Current status and pros-pects of radiopharmaceuticals in china[J].Journal of Isotopes,2011,23(3):129-139(in Chinese).
[7]中华医学会核医学分会.2012年全国核医学现状普查简报引用[J].中华核医学与分子影像杂志,2012,32(5):357.Chinese Society of Nuclear Medicine.2012Nation-al census of nuclear medicine status briefing[J].Chin Journal of Nuclear Medicine and Molecular Imaging,2012,32(5):357(in Chinese).
[8]HEGER AS,WILLIAM B.Comparison of Char-acteristics of Solution and Conventional Reactors for 99 Mo Production[J].Nuclear Technology,1997,118(5):142-150.
[9]邓启民,程作用,李茂良,等.利用MIPR生产99 Mo、131 I和89 Sr的可行性研究[J].核动力工程,2011(6):79-83.Deng Qimin,Li Maoliang,Cheng Zuoyong.Fea-sibility production of molybdenum-99,iodine-131,strontium-99through medical isotope produc-tion reactor[J].Nuclear Power Engineering,2011,(6):79-83(in Chinese).
[10]邓启民,李茂良,程作用.利用医用同位素生产堆生产89 Sr[J].同位素,2007,20(3):185-188.Deng Qimin,Li Maoliang,Cheng Zuoyong.Strontium-99production through medical isotope production reactor[J].Journal of Isotopes,2007,20(3):112-115(in Chinese).
[11]邓启民,李茂良,程作用.医用同位素生产堆(MIPR)生产99 Mo的应用前景[J].核科学与工程,2006,26(2):68-70.Deng Qimin,Li Maoliang,Cheng Zuoyong.Ap-plication of molybdenum-99production through medical isotope production reactor(MIPR)[J].Chinese Journal of Nuclear Science and Engineer-ing,2006,26(2):68-70(in Chinese).
[12]Jongen Y.Adonis:The Proton-driven Neutron Source for Radioisotope Production[C]//IAEA-TECDOC-1065,Vienna:IAEA,1999:139-146.